Cargando…
Fingolimod Associated Bilateral Cystoid Macular Edema—Wait and See?
Fingolimod 0.5-mg once-daily is an approved therapy for patients with relapsing–remitting multiple sclerosis (MS). Several pivotal and real-world studies have demonstrated that fingolimod is associated with the development of macular edema (ME). Herein, we present a case of a diabetic MS patient who...
Autores principales: | Pul, Refik, Osmanovic, Alma, Schmalstieg, Holger, Pielen, Amelie, Pars, Kaweh, Schwenkenbecher, Philipp, Sühs, Kurt Wolfram, Yildiz, Özlem, Frank, Benedikt, Stangel, Martin, Skripuletz, Thomas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5187906/ https://www.ncbi.nlm.nih.gov/pubmed/27983657 http://dx.doi.org/10.3390/ijms17122106 |
Ejemplares similares
-
Intrathecal synthesis of anti-Hu antibodies distinguishes patients with paraneoplastic peripheral neuropathy and encephalitis
por: Schwenkenbecher, Philipp, et al.
Publicado: (2016) -
Common and uncommon neurological manifestations of neuroborreliosis leading to hospitalization
por: Schwenkenbecher, Philipp, et al.
Publicado: (2017) -
Longitudinal time-domain optic coherence study of retinal nerve fiber layer in IFNβ-treated and untreated multiple sclerosis patients
por: PUL, REFIK, et al.
Publicado: (2016) -
Varicella zoster virus infections in neurological patients: a clinical study
por: Skripuletz, Thomas, et al.
Publicado: (2018) -
Fumaric Acids Directly Influence Gene Expression of Neuroprotective Factors in Rodent Microglia
por: Kronenberg, Jessica, et al.
Publicado: (2019)